An experience with transvaginal sonography in gynaecologic tumour surveillance.
Surveillance of gynaecologic cancer patients treated with a curative intent involves frequent presentations by the patient for a targeted history, detailed general and pelvic examination, including Pap smear. One of the aims of such surveillance is to detect potentially curable recurrences early to allow the initiation of further therapy, hopefully to attain eradication of the recurrent tumour. Six cases are presented where the prudent use of transvaginal sonography (TVS) was found to be useful in the exclusion of recurrent tumour in patients with symptoms; early diagnosis in patients who were asymptomatic; confirmation of disease in those with symptoms; to evaluate patients with obliterated upper vaginas due to therapy, and follow-up of those with confirmed recurrence as a form of disease marker.
Carter
J
J
Sydney Gynaecologic Oncology Group, Royal Prince Alfred Hospital, New South Wales, Australia.
D000359:Aftercare / Q000379:methods*; D001706:Biopsy; D018394:CA-125 Antigen / Q000097:blood; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000097:blood / Q000000981:diagnostic imaging* / Q000276:immunology / Q000628:therapy; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000276:immunology / Q000628:therapy; D014463:Ultrasonography; D014594:Uterine Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000276:immunology / Q000628:therapy; D014621:Vagina / Q000000981:diagnostic imaging
D018394:CA-125 Antigen